03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Decadron Tablets : | |
Type | Medicine Authorised |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Algorithm Laboratories |
Responsible Party | Algorithm S.A.L. |
Origin | Lebanon |
Manufacturer | Algorithm Pharmaceutical Manufacturers |
Origin | Lebanon |
ATC | H02AB02 |
Revision Date | 01/07/2010 |
Decadron Tablets :
Decadron Tablets :
Decadron Tablets :
Decadron Tablets :
Decadron Tablets :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Decadron Tablets :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Not known |
Alkalosis hypokalaemic | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Aseptic necrosis of head and neck of femur | Not known |
Carbohydrate tolerance decreased | Not known |
Cataract subcapsular | Not known |
Cephalea | Not known |
Congestive heart failure | Not known |
Convulsion | Not known |
Dermatitis allergic | Not known |
Ecchymosis | Not known |
Erythema | Not known |
Exophthalmos (Bulging eyes) | Not known |
Fracture vertebral | Not known |
Gastric haemorrhage | Not known |
Gastrointestinal perforation | Not known |
Gastrointestinal ulcer | Not known |
Glaucoma | Not known |
Growth retardation | Not known |
Hiccups | Not known |
Hirsutism | Not known |
Hyperhidrosis | Not known |
Hypersensitivity | Not known |
Hypertension | Not known |
Increased appetite | Not known |
Increased insulin requirement | Not known |
Intracranial hypertension (Intracranial pressure increased) | Not known |
Intraocular pressure increased | Not known |
Large intestine perforation | Not known |
Latent diabetes | Not known |
Malaise | Not known |
Menstruation irregular | Not known |
Muscle wasting | Not known |
Myasthenia | Not known |
Myocardial rupture | Not known |
Nausea | Not known |
Nitrogen balance negative | Not known |
Oesophagitis ulcerative | Not known |
Osteoporosis | Not known |
Pancreatitis | Not known |
Papilloedema | Not known |
Pathologic fracture of tibia and fibula | Not known |
Petechiae | Not known |
Pituitary insufficiency | Not known |
Potassium low | Not known |
Psychic disturbance | Not known |
Secondary adrenocortical insufficiency | Not known |
Skin thinning | Not known |
Small intestinal perforation | Not known |
Sodium retention | Not known |
Steroid myopathy | Not known |
Tendon rupture | Not known |
Thromboembolism | Not known |
Urticaria | Not known |
Vertigo | Not known |
Water retention | Not known |
Weight increased (weight gain) | Not known |
Wound healing disturbance of | Not known |
Decadron Tablets :
NB : Products With Same Indication |
Different Units By MoH Code
Decadron Tablets MoH 4292 :
Form | Tablet |
Packaging | Blisters |
Package Size | Box of 30 |
Strength | 0.5mg |
Storage Condition | <30°C protect from light |
Public Price | 367152.49 L.L. |
Stratum | A1 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 6930 |
Submission date | 01/01/1993 |
Registration Year | 1993 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File